Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma

Experimental Cell Research

Volumn 317, Issue 11, 2011, Pages 1580-1589

  Joshi, Ayesha ^a   Ellenson, Lora Hedrick ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biallelic inactivation; Endometrial carcinoma; Pten

Indexed keywords

ADENOVIRUS VECTOR; CRE RECOMBINASE; CYCLIN D3; ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; FEMALE; GENE DELETION; GENE INACTIVATION; HOMOZYGOSITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; MUS;

EID: 79956301068     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.006     Document Type: Article

References (39)

1. Di Cristofano A., Ellenson L.H. Endometrial carcinoma. Annu. Rev. Pathol. 2007, 2:57-85.
2. Tashiro H., Blazes M.S., Wu R., Cho K.R., Bose S., Wang S.I., Li J., Parsons R., Ellenson L.H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997, 57:3935-3940.
3. Kong D., Suzuki A., Zou T.T., Sakurada A., Kemp L.W., Wakatsuki S., Yokoyama T., Yamakawa H., Furukawa T., Sato M., Ohuchi N., Sato S., Yin J., Wang S., Abraham J.M., Souza R.F., Smolinski K.N., Meltzer S.J., Horii A. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet. 1997, 17:143-144.
4. Risinger J.I., Hayes A.K., Berchuck A., Barrett J.C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997, 57:4736-4738.
5. Bussaglia E., del Rio E., Matias-Guiu X., Prat J. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum. Pathol. 2000, 31:312-317.
6. Levine R.L., Cargile C.B., Blazes M.S., van Rees B., Kurman R.J., Ellenson L.H. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 1998, 58:3254-3258.
7. Maxwell G.L., Risinger J.I., Gumbs C., Shaw H., Bentley R.C., Barrett J.C., Berchuck A., Futreal P.A. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res. 1998, 58:2500-2503.
8. Mutter G.L., Lin M.C., Fitzgerald J.T., Kum J.B., Baak J.P., Lees J.A., Weng L.P., Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl Cancer Inst. 2000, 92:924-930.
9. Salmena L., Carracedo A., Pandolfi P.P. Tenets of PTEN tumor suppression. Cell 2008, 133:403-414.
10. Lu T.L., Chang J.L., Liang C.C., You L.R., Chen C.M. Tumor spectrum, tumor latency and tumor incidence of the Pten-deficient mice. PLoS ONE 2007, 2:e1237.
11. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
12. Podsypanina K., Ellenson L.H., Nemes A., Gu J., Tamura M., Yamada K.M., Cordon-Cardo C., Catoretti G., Fisher P.E., Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. U.S.A. 1999, 96:1563-1568.
13. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 1998, 19:348-355.
14. Wang H., Douglas W., Lia M., Edelmann W., Kucherlapati R., Podsypanina K., Parsons R., Ellenson L.H. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am. J. Pathol. 2002, 160:1481-1486.
15. Wang H., Joshi A., Iaconis L., Solomon G.J., Xiang Z., Verhage H.G., Douglas W., Ronnett B.M., Ellenson L.H. Oviduct-specific glycoprotein is a molecular marker for invasion in endometrial tumorigenesis identified using a relevant mouse model. Int. J. Cancer 2009, 124:1349-1357.
16. Lacey J.V., Mutter G.L., Ronnett B.M., Ioffe O.B., Duggan M.A., Rush B.B., Glass A.G., Richesson D.A., Chatterjee N., Langholz B., Sherman M.E. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res. 2008, 68:6014-6020.
17. Ma X., Ziel-van der Made A.C., Autar B., van der Korput H.A., Vermeij M., van Duijn P., Cleutjens K.B., de Krijger R., Krimpenfort P., Berns A., van der Kwast T.H., Trapman J. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res. 2005, 65:5730-5739.
18. Backman S.A., Ghazarian D., So K., Sanchez O., Wagner K.U., Hennighausen L., Suzuki A., Tsao M.S., Chapman W.B., Stambolic V., Mak T.W. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc. Natl Acad. Sci. U.S.A. 2004, 101:1725-1730.
19. Fraser M.M., Zhu X., Kwon C.H., Uhlmann E.J., Gutmann D.H., Baker S.J. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 2004, 64:7773-7779.
20. Kwon C.H., Zhu X., Zhang J., Knoop L.L., Tharp R., Smeyne R.J., Eberhart C.G., Burger P.C., Baker S.J. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet. 2001, 29:404-411.
21. Maitra A., Hruban R.H. A new mouse model of pancreatic cancer: PTEN gets its Akt together. Cancer Cell 2005, 8:171-172.
22. Daikoku T., Hirota Y., Tranguch S., Joshi A.R., DeMayo F.J., Lydon J.P., Ellenson L.H., Dey S.K. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008, 68:5619-5627.
23. Grant K.S., Wira C.R. Effect of mouse uterine stromal cells on epithelial cell transepithelial resistance (TER) and TNFalpha and TGFbeta release in culture. Biol. Reprod. 2003, 69:1091-1098.
24. Beauparlant S.L., Read P.W., Di Cristofano A. In vivo adenovirus-mediated gene transduction into mouse endometrial glands: a novel tool to model endometrial cancer in the mouse. Gynecol. Oncol. 2004, 94:713-718.
25. Contreras C.M., Gurumurthy S., Haynie J.M., Shirley L.J., Akbay E.A., Wingo S.N., Schorge J.O., Broaddus R.R., Wong K.K., Bardeesy N., Castrillon D.H. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. Cancer Res. 2008, 68:759-766.
26. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
27. Chen M.L., Xu P.Z., Peng X.D., Chen W.S., Guzman G., Yang X., Di Cristofano A., Pandolfi P.P., Hay N. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice. Genes Dev. 2006, 20:1569-1574.
28. Mylonas I. Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas. Oncol Rep 2010, 24:385-393.
29. Campbell R.A., Bhat-Nakshatri P., Patel N.M., Constantinidou D., Ali S., Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001, 276:9817-9824.
30. Vilgelm A., Lian Z., Wang H., Beauparlant S.L., Klein-Szanto A., Ellenson L.H., Di Cristofano A. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res. 2006, 66:3375-3380.
31. Ignar-Trowbridge D.M., Nelson K.G., Ross K.A., Washburn T.F., Korach K.S., McLachlan J.A. Localization of the estrogen receptor in uterine cells by affinity labeling with [3H]tamoxifen aziridine. J. Steroid Biochem. Mol. Biol. 1991, 39:131-132.
32. Cooke P.S., Buchanan D.L., Young P., Setiawan T., Brody J., Korach K.S., Taylor J., Lubahn D.B., Cunha G.R. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc. Natl Acad. Sci. U.S.A. 1997, 94:6535-6540.
33. Buchanan D.L., Setiawan T., Lubahn D.B., Taylor J.A., Kurita T., Cunha G.R., Cooke P.S. Tissue compartment-specific estrogen receptor-alpha participation in the mouse uterine epithelial secretory response. Endocrinology 1999, 140:484-491.
34. Kurita T., Lee K.J., Cooke P.S., Taylor J.A., Lubahn D.B., Cunha G.R. Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biol. Reprod. 2000, 62:821-830.
35. Astrahantseff K.N., Morris J.E. Estradiol-17 beta stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately. In Vitro Cell. Dev. Biol. Anim. 1994, 30A:769-776.
36. Shiozawa T., Miyamoto T., Kashima H., Nakayama K., Nikaido T., Konishi I. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 2004, 23:8603-8610.
37. Altucci L., Addeo R., Cicatiello L., Germano D., Pacilio C., Battista T., Cancemi M., Petrizzi V.B., Bresciani F., Weisz A. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. Endocrinology 1997, 138:978-984.
38. Zhuang Y.H., Sarca D., Weisz A., Altucci L., Cicatiello L., Rollerova E., Tuohimaa P., Ylikomi T. Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27(kip1) expression by estrogen in rat endometrium. J. Steroid Biochem. Mol. Biol. 2001, 78:193-199.
39. Memarzadeh S., Zong Y., Janzen D.M., Goldstein A.S., Cheng D., Kurita T., Schafenacker A.M., Huang J., Witte O.N. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proc Natl Acad Sci U S A 2010, 104:17298-17303.